Lomitapide Observational Worldwide Evaluation Registry
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Lomitapide (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Acronyms LOWER
- Sponsors Aegerion Pharmaceuticals
- 16 Nov 2016 Results (n=143, data cut off: March 2016) presented at the 89th Annual Scientific Sessions of the American Heart Association
- 10 Nov 2015 Results were poster presented at the American Heart Associations (AHA) Scientific Sessions 2015.
- 10 Nov 2015 Results of 84 patients enrolled till March 2015 were published in an Aegerion Pharmaceuticals media release.